We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Acrux is a biotechnology business based in Australia. Acrux shares (ACR) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian dollars. Acrux has a trailing 12-month revenue of around $1.3 million. If you're looking to buy shares, check out the steps below.
Our top pick for
US stocks
Our top pick for
Best overall broker
Our top pick for
Best low-cost broker
| 52-week range | $0.06 - $0.16 |
|---|---|
| 50-day moving average | $0.0752 |
| 200-day moving average | $0.0999 |
| Target price | $0.23 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-0.038 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. However, this is not a recommendation. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the last close of A$0.055
| 1 week (2022-06-17) | -14.06% |
|---|---|
| 1 month (2022-05-27) | -16.67% |
| 3 months (2022-03-28) | -36.05% |
| 6 months (2021-12-24) | -45.00% |
| 1 year (2021-06-28) | -57.69% |
|---|---|
| 2 years (2020-06-26) | -63.33% |
| 3 years (2019-06-28) | -70.27% |
| 5 years (2017-06-26) | -75.56% |
| Revenue TTM | $1.3 million |
|---|---|
| Gross profit TTM | $-7,591,000 |
| Return on assets TTM | -53.98% |
| Return on equity TTM | -82.09% |
| Profit margin | 0% |
| Book value | 0.046 |
| Market capitalisation | $18.5 million |
TTM: trailing 12 months
We're not expecting Acrux to pay a dividend over the next 12 months.
Over the last 12 months, Acrux's shares have ranged in value from as little as $0.06 up to $0.16. A popular way to gauge a stock's volatility is its "beta".
Beta measures a share's volatility in relation to the market. The market (AU average) beta is 1, while Acrux's is 0.9954. This would suggest that Acrux's shares are less volatile than average (for this exchange).
Acrux Limited, together with its subsidiaries, develops and commercializes generic and specialty topical pharmaceuticals in Australia, Europe, the United States, and internationally. The company offers testosterone solutions, such as oral tablets, buccal tablets, subcutaneous pellets, transdermal patches, injections, and topical gels for treatment of adult males who have low or no testosterone. It also provides estradiol sprays for women under the Evamist and Lenzetto brand names for the treatment of flushes associated with menopause. Acrux Limited was incorporated in 1998 and is based in West Melbourne, Australia.
Steps to owning and managing Nexgen Energy shares.
Steps to owning and managing Keypath Education shares.
If you want to directly fund climate solutions a green bond is a great place to start. Here is how they work.
What's the best way to invest money in Australia? Find out about robo advisors, index funds, cryptocurrency and more in this guide.
Steps to owning and managing EBR Systems shares.
Steps to owning and managing 5E Advanced Materials shares.
Steps to owning and managing Leo lithium shares.
Steps to owning and managing Besra Gold shares.
Steps to owning and managing The Lottery Corporation shares.
Steps to owning and managing Endeavour Group shares.
